Alert: Rating Upgrade (4/8/24)-Celldex Therapeutics Inc (NASDAQ: CLDX).
Stock Rating Upgrade The Value Trend Rating for Celldex Therapeutics Inc (NASDAQ: CLDX) improved in the last week from D to C reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are […]